Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatment.
- 1 August 2004
- journal article
- Published by Springer Science and Business Media LLC in Digestive Diseases and Sciences
- Vol. 49 (7), 1190-1195
- https://doi.org/10.1023/b:ddas.0000037811.48575.da
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Ursodeoxycholic acid for primary biliary cirrhosisPublished by Wiley ,2001
- A comparative study of antibody expressions in primary biliary cirrhosis and autoimmune cholangitis using phage displayHepatology, 2001
- The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosisHepatology, 2000
- Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trialJournal of Hepatology, 2000
- Is serum bilirubin concentration the only valid prognostic marker in primary biliary cirrhosis?Hepatology, 1999
- Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosisHepatology, 1999
- The ursodeoxycholic acid story in primary biliary cirrhosis.Gut, 1995
- Letters to the editorStatistics in Medicine, 1992
- Application of the Mayo Primary Biliary Cirrhosis Survival Model to Mayo Liver Transplant PatientsMayo Clinic Proceedings, 1989
- Efficacy of Liver Transplantation in Patients with Primary Biliary CirrhosisThe New England Journal of Medicine, 1989